Related Experiment Video
Updated: May 19, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Cellular growth factors in relation to mortality from cardiovascular disease in middle-aged Japanese: the JACC study
Hiroyasu Iso1, Koutatsu Maruyama, Satoyo Ikehara
1Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Japan. iso@pbhel.med.osaka-u.ac.jp
Insights
Insulin-like growth factor I (IGF-I) was linked to lower intraparenchymal hemorrhage risk, while transforming growth factor beta 1 (TGF-β1) was associated with reduced ischemic stroke mortality. These findings suggest cellular growth factors may influence stroke development.
Area of Science:
- Cardiovascular Epidemiology
- Biomarkers in Disease
- Cellular Biology and Disease Mechanisms
Background:
- Limited population-based data exists on cellular growth factors and cardiovascular disease.
- Cellular growth factors play roles in cell proliferation and tissue repair, potentially impacting cardiovascular health.
Purpose of the Study:
- To investigate the association between specific cellular growth factors and mortality from stroke and coronary heart disease.
- To explore the potential role of cellular proliferation in cardiovascular disease outcomes.
Main Methods:
- A nested case-control study within the JACC prospective cohort (39,242 participants aged 40-79).
- Measurement of serum insulin-like growth factors I, II (IGF-I, IGF-II), binding protein-3 (IGFBP-3), and transforming growth factor beta 1 (TGF-β1).
- Matching of cases and controls for sex, age, residence, and serum storage year.
Main Results:
- A 9-year follow-up identified 233 stroke deaths and 97 coronary heart disease deaths.
- Higher IGF-I levels showed an inverse association with intraparenchymal hemorrhage mortality (OR 0.31; 95% CI 0.14-0.71).
- Higher TGF-β1 levels were inversely associated with ischemic stroke mortality (OR 0.58; 95% CI 0.34-0.98).
- IGF-II and IGFBP-3 were not significantly associated with any studied mortality outcomes.
Conclusions:
- IGF-I is inversely associated with intraparenchymal hemorrhage mortality.
- TGF-β1 is inversely associated with ischemic stroke mortality.
- These findings suggest a role for cellular proliferation in stroke pathogenesis or prognosis.
Objective:
Limited evidence has been available on the relationships of cellular growth factors with cardiovascular disease in population-based samples.
Methods:
We conducted a nested case-control study under a large prospective cohort study (JACC study) where a total of 39,242 subjects aged 40-79 years provided serum sample. We measured cellular growth factors [insulin-like growth factors I, II and binding protein-3 (IGF-I, IGF-II and IGFBP-3) and transforming growth factor (TGF-β1)] among cases and controls, matched for sex, age, area of residence and year of serum storage.
Results And Conclusions:
During the follow-up for 9 years, there were 233 deaths from total stroke (49 subarachnoid hemorrhages, 55 intraparenchymal hemorrhages, 71 ischemic strokes), and 97 deaths from coronary heart disease. The multivariable odds ratio (95%CI) of intraparenchymal hemorrhage associated with a 1-SD increment of IGF-I (men:4 8 ng/ml, women: 61 ng/ml) was 0.31 (0.14-0.71). That of ischemic stroke associated with a 1-SD increment of TGF-β1 (men: 8.0 ng/ml, women: 10.9 ng/ml) was 0.58 (0.34-0.98). Serum IGF-II and IGFBP-3 were not associated with mortality from any outcomes. In conclusion, IGF-I was inversely associated with mortality from intraparenchymal hemorrhage while TGF-β1 was so with ischemic stroke, suggesting potential roles of cellular proliferation in the development or prognosis of stroke.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
